Literature DB >> 23380666

The epidemiology and clinical characteristics of young children hospitalized with respiratory syncytial virus infections in Guatemala (2007-2010).

Gayle Fischer Langley1, John McCracken, Wences Arvelo, Alejandra Estevez, Gissela Villarruel, Mila Prill, Marika Iwane, Jennifer Gray, Fabiola Moscoso, Lissette Reyes, Juan Carlos Moir, Jose Ortiz, Kim Lindblade.   

Abstract

BACKGROUND: There have been few population-based studies from Central America on respiratory syncytial virus (RSV) infections in young children. We report population-based incidence rates and describe epidemiological and clinical characteristics of children <5 years old hospitalized with RSV infections in Guatemala.
METHODS: Prospective, active hospital-based surveillance for acute respiratory infections in children <5 years old was conducted at 3 hospitals in Guatemala from November 2007 through July 2010. RSV hospitalization rates were calculated for areas where the catchment population could be defined. Comparisons were made between children who were RSV-positive and RSV-negative.
RESULTS: RSV was detected in 549 (25%) of enrolled children. Overall, annual rates of RSV hospitalizations ranged from 5.9 to 45.9 and 2.0 to 13.7 per 1000 children <1 year old and <5 years old, respectively, but varied by location and calendar year. Rates generally decreased with age--children <6 months had rates up to 30 times higher than older children, but children >12 months old still had rates up to 5.5 per 1000 per year and accounted for 42% of deaths. Children with RSV infections were more likely to have signs of respiratory distress (85% versus 63%, P < 0.001) compared with those without RSV infections, but case fatality ratios were similar (3-4%).
CONCLUSIONS: The large burden and severity of RSV infections in young Guatemalan children is similar in magnitude and age distribution to RSV disease burdens found in other developing countries and suggests that this population would benefit from prevention strategies, including vaccines against RSV that are currently under development.

Entities:  

Mesh:

Year:  2013        PMID: 23380666     DOI: 10.1097/INF.0b013e318289e3bc

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  10 in total

1.  Detection of Multiple Respiratory Viruses Associated With Mortality and Severity of Illness in Children.

Authors:  Kyle J Rehder; Elizabeth A Wilson; Kanecia O Zimmerman; Coleen K Cunningham; David A Turner
Journal:  Pediatr Crit Care Med       Date:  2015-09       Impact factor: 3.624

2.  Surveillance for hospitalized acute respiratory infection in Guatemala.

Authors:  Jennifer R Verani; John McCracken; Wences Arvelo; Alejandra Estevez; Maria Renee Lopez; Lissette Reyes; Juan Carlos Moir; Chris Bernart; Fabiola Moscoso; Jennifer Gray; Sonja J Olsen; Kim A Lindblade
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

3.  Comparative epidemiology of human metapneumovirus- and respiratory syncytial virus-associated hospitalizations in Guatemala.

Authors:  John P McCracken; Wences Arvelo; José Ortíz; Lissette Reyes; Jennifer Gray; Alejandra Estevez; Oscar Castañeda; Gayle Langley; Kim A Lindblade
Journal:  Influenza Other Respir Viruses       Date:  2014-04-25       Impact factor: 4.380

4.  Assessing the Incidence of Symptomatic Respiratory Syncytial Virus Illness Within a Prospective Birth Cohort in Managua, Nicaragua.

Authors:  John Kubale; Guillermina Kuan; Lionel Gresh; Sergio Ojeda; Eduardo Azziz-Baumgartner; Nery Sanchez; Roger Lopez; Eva Harris; Angel Balmaseda; Aubree Gordon
Journal:  Clin Infect Dis       Date:  2020-05-06       Impact factor: 9.079

Review 5.  Can we distinguish respiratory viral infections based on clinical features? A prospective pediatric cohort compared to systematic literature review.

Authors:  Xiaolin Ma; Tim Conrad; Maren Alchikh; Janine Reiche; Brunhilde Schweiger; Barbara Rath
Journal:  Rev Med Virol       Date:  2018-07-24       Impact factor: 6.989

6.  Evaluation of the collaborative integrated surveillance system (ViCo) in Guatemala: a qualitative study on lessons learned and future perspectives.

Authors:  Jahn Jaramillo; Mariangeli Freitas Ning; Loren Cadena; Michael Park; Terrence Lo; Emily Zielinski-Gutierrez; Andres Espinosa-Bode; Marines Reyes; Maria Del Rosario Polo; Olga Henao
Journal:  BMC Public Health       Date:  2022-02-18       Impact factor: 3.295

7.  Evaluation of case definitions for estimation of respiratory syncytial virus associated hospitalizations among children in a rural community of northern India.

Authors:  Siddhartha Saha; Bharti Gaur Pandey; Avinash Choudekar; Anand Krishnan; Susan I Gerber; Sanjay K Rai; Pratibha Singh; Mandeep Chadha; Renu B Lal; Shobha Broor
Journal:  J Glob Health       Date:  2015-12       Impact factor: 4.413

8.  Factors associated with fatal cases of acute respiratory infection (ARI) among hospitalized patients in Guatemala.

Authors:  Sara Tomczyk; John P McCracken; Carmen Lucia Contreras; Maria Renee Lopez; Chris Bernart; Juan Carlos Moir; Kenneth Escobar; Lisette Reyes; Wences Arvelo; Kim Lindblade; Leonard Peruski; Joe P Bryan; Jennifer R Verani
Journal:  BMC Public Health       Date:  2019-05-03       Impact factor: 3.295

9.  Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014-15.

Authors:  Carmen S Arriola; Lindsay Kim; Gayle Langley; Evan J Anderson; Kyle Openo; Andrew M Martin; Ruth Lynfield; Erica Bye; Kathy Como-Sabetti; Arthur Reingold; Shua Chai; Pam Daily; Ann Thomas; Courtney Crawford; C Reed; S Garg; Sandra S Chaves
Journal:  J Pediatric Infect Dis Soc       Date:  2020-11-10       Impact factor: 3.164

10.  Respiratory Syncytial Virus-related Death in Children With Down Syndrome: The RSV GOLD Study.

Authors:  Yvette N Löwensteyn; Emily W E M Phijffer; Juliette V L Simons; Nienke M Scheltema; Natalie I Mazur; Harish Nair; Louis J Bont
Journal:  Pediatr Infect Dis J       Date:  2020-08       Impact factor: 3.806

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.